| In-Depth Proteomics of Ovarian Cancer Ascites: Combining Shotgun Proteomics and Selected Reaction Monitoring Mass Spectrometry. | |
| | |
MedLine Citation:
|
PMID: 21491939 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Epithelial ovarian cancer (EOC) is the most common gynecological cancer and the ninth most common cancer overall. Major problems associated with EOC include poorly characterized disease progression, disease heterogeneity, lack of early detection markers and the development of chemoresistance. Early detection and treatment of EOC would significantly benefit from routine screening tests on available biofluids. We built on our experience in analyzing ovarian cancer ascites and present an analysis pipeline that combines discovery-based proteomics, bioinformatics prioritization and targeted proteomics quantification using Selected Reaction Monitoring Mass Spectrometry (SRM-MS). Ascitic fluids from patients with serous-type epithelial ovarian cancer were analyzed using comprehensive shotgun proteomics and compared to noncancerous ascitic fluids from patients with benign ovarian tumors. Integration of our data with published mRNA transcriptomic and proteomic data sets led to a panel of 51 candidate proteins. Systematic SRM-MS assay development was performed for a subset of these proteins using both synthetic peptides (13 proteins) and stable isotope labeled standards (4 proteins). Subsequently, precise relative quantification by stable isotope dilution-SRM (SID-SRM) in independent ascites and serum samples was performed as a proof-of-concept validation. The analysis strategy outlined here lays the foundation for future experiments using both larger numbers of patient samples and additional candidate proteins, and provides a template for the proteomics-based discovery of cancer biomarkers. |
| | |
Authors:
|
Sarah Elschenbroich; Vladimir Ignatchenko; Blaise Clarke; Steve E Kalloger; Paul C Boutros; Anthony O Gramolini; Patricia Shaw; Igor Jurisica; Thomas Kislinger |
Related Documents
:
|
21103379 - Silencing of ptk7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondri... 16140939 - Accumulation of p53 and reductions in xiap abundance promote the apoptosis of prostate ... 21203759 - Cancer of the gastric cardia is rising in incidence in an asian population and is assoc... 23313739 - Microrna-182 plays an onco-mirna role in cervical cancer. 18841289 - Simvastatin reduces the production of prothrombotic prostasomes in human prostate cance... 23234499 - U-pa inhibitor amiloride suppresses peritoneal metastasis in gastric cancer. 9301039 - Ultraviolet radiation and skin cancer of humans. 14722849 - Colon polyps and cancer. 2979859 - Prostate-derived growth factors for bone cells: implications for bone physiology and pa... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-14 |
Journal Detail:
|
Title: Journal of proteome research Volume: - ISSN: 1535-3907 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101128775 Medline TA: J Proteome Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Ontario Cancer Institute, University Health Network , Toronto, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ligand-Promoted C-3 Selective C-H Olefination of Pyridines with Pd Catalysts.
Next Document: Rapid Access to Unusual Solid-State Luminescent Merocyanines by a Novel One-Pot Three-Component Synt...